Results 121 to 130 of about 5,550 (180)

Central Nervous System Lymphoma Harboring the JAK2 V617F Mutation That Developed after a 20-year History of Polycythemia Vera. [PDF]

Intern Med, 2018
Kajikawa N, Seki Y, Fujio T, Okoshi Y, Hori M, Saito H, Iijima T, Kojima H.   +7 more
europepmc   +1 more source

Novel germline <i>JAK2 L808W</i> and <i>E305Vfs*4</i> mutations in familial essential thrombocythemia: Evidence from two pedigrees. [PDF]

Chin J Cancer Res
Liu J, Hu W, Wang C, Zhang Y, Ouyang M, Ren H, Zhang M.   +6 more
europepmc   +1 more source

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients. [PDF]

Turk J Med Sci
Aydin GS, Aksoy E, Yönal Hindilerden İ, Dağlar Aday A, Gültürk E, Nalçaci M, Hindilerden F.   +6 more
europepmc   +1 more source

Lentiginoses in polycythemia vera patient: Is there a role for JAK2 (V617F) mutation? [PDF]

JAKSTAT, 2015
Uzuncakmak TK, Yilmaz S, Karadag AS, Akdeniz N, Akalin I.   +4 more
europepmc   +1 more source

Hematopoietic JAK2V617F mutation-induced reprogramming of blood and bone marrow megakaryocytes. [PDF]

Blood Adv
Lu S, Karkempetzaki AI, Huang N, Zhang C, Murphy GJ, Ravid K.   +5 more
europepmc   +1 more source

Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F-mutated essential thrombocythemia: a case report. [PDF]

Front Immunol
Ashida Y, Ota S, Ishidoya N, Murai Y, Amenomori K, Hasui K, Kawaguchi S, Yamaguchi S, Hiraga H, Kamata K, Ichikawa H, Tomita H, Yu Z, Minakawa M, Sakuraba H.   +14 more
europepmc   +1 more source

Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction. [PDF]

Blood Adv
Gill H, Au L, Yim R, Lee P, Li V, Chin L, Zhang Q, Chan PY, Lee CYY, Wu TKY, Leung GMK, Kwong YL.   +11 more
europepmc   +1 more source

A single <i>JAK2</i>-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice. [PDF]

Hemasphere
Kimmerlin Q, Hilpert M, Hansen N, Guy A, Usart M, Stetka J, Sobieralski P, Almeida Fonseca T, Hao-Shen H, Skoda RC.   +9 more
europepmc   +1 more source

Thrombosis in primary myelofibrosis: the influence of cohort composition and disease biology. [PDF]

Blood Adv
Barbui T, De Stefano V, Tefferi A, Vannucchi AM.   +3 more
europepmc   +1 more source